Oncotaxel 260 Injection
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Paclitaxel (260mg)
Overview Oncotaxel 260 Injection
Taxotere 260mg Injection is a chemotherapy agent indicated for breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your specific condition and may vary. Strictly adhere to your prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be immediately apparent, requiring several weeks or months; discontinue only under medical supervision. Typical side effects include nausea, vomiting, and fatigue. More serious reactions like edema (hand and lip swelling), alopecia, and weight increase are possible. Concomitant medications may mitigate these effects; however, report unusual bruising, bleeding, sore throat, mouth sores, or fever immediately. This medication can suppress blood cell counts (red and white), increasing infection risk; regular blood work, including liver function tests, is mandatory. Inform your doctor of pre-existing heart, liver, or kidney conditions, and all current medications (including anti-infectives), as interactions are possible. This treatment is contraindicated during pregnancy and breastfeeding. Reliable contraception for both partners is crucial throughout the treatment period.
Primary Ingredients of Oncotaxel 260 Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Oncotaxel 260 Injection
Cancers of the breast, lung (non-small cell type), and pancreas
Major Benefits of Oncotaxel 260 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Oncotaxel 260 Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Oncotaxel 260 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Oncotaxel 260 Injection works:
Oncotaxel 260 Injection is a chemotherapy agent that targets cancer cell replication. Its mechanism of action involves disrupting microtubules, essential components of cell division. This disruption inhibits cancer cell proliferation, ultimately leading to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Oncotaxel 260 Injection is hazardous.
PregnancyCONSULT YOUR DOCTOR
Administering Oncotaxel 260 Injection during pregnancy poses a confirmed risk to the fetus. Nevertheless, in exceptional circumstances involving a life-threatening condition, a physician might consider its use if the potential advantages outweigh the hazards. Physician consultation is advised.
Breast feedingUNSAFE
Breastfeeding is contraindicated during treatment with Oncotaxel 260 Injection due to the potential for infant toxicity.
DrivingUNSAFE
Administering Oncotaxel 260 Injection might induce adverse reactions impacting driving capabilities. While there's no inherent prohibition against driving between treatment cycles, consider that this medication includes alcohol; driving may therefore be inadvisable.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Oncotaxel 260 Injection; no dosage alteration is advised. Nevertheless, consult your physician regarding any pre-existing kidney conditions.
LiverCAUTION
Patients with liver impairment should receive Oncotaxel 260 Injection with close monitoring; dosage modification may be necessary. Physician consultation is advised. Oncotaxel 260 Injection is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Oncotaxel 260 Injection :
NA
Facts to Know About Oncotaxel 260 Injection
| Label | Value |
|---|---|
| Chemical Type | Taxane Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Taxanes: Antimicrotubule Agents |
3,018 People bought this recently